Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Interview: Mark Chapman, International CEO, Life Healthcare

What are South African hospital group Life Healthcare's plans for its international division, mainly comprised of pan-European imaging operator Alliance Medical? In a long and wide-ranging discussion, Chapman talks about expansion in South Africa and one to two new countries, 'winners and losers' in the imaging AI market, tariff pressure across Europe and what the first new potential drug therapy for Alzheimer's in 18 years means for its PET-CT business.
March 24, 2021

Vaccines causing minimal headwinds in COVID-19 testing volumes

HBI analysis of COVID-19 testing volumes and pricing reveals how vaccine programmes and the rise of antigen tests might impact future growth for the lab groups. PCR volumes and have dropped 16% in the UK since it started vaccinating its population and one lab group is expecting a 35% to 50% drop in COVID revenue this year.
March 11, 2021

$20bn merger could transform Brazilian healthcare market

A $20bn merger between two giants of Brazilian healthcare, listed HMOs Hapvida Participacoes e Investimentos SA and Notre Dame Intermedica Participacoes SA (GNDI), will create one of the world’s biggest companies providing verticalized health-care solutions. HBI looks at the deal in detail, and talks to a Brazil-based operator to find out more.
March 4, 2021

Amedes for sale as Synlab forecasts future organic growth to settle about 3%

Europe's largest lab group Synlab forecasts that it will see 3+% of annual organic growth over the mid-term, saying that testing will remain a core part of pandemic control. Other lab groups clearly agree with that punt, with news that smaller rival Amedes reportedly is preparing for sale.
February 25, 2021

Synlab and Cerba looking for exits, while Unilabs in ‘no rush’

The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite. 
February 15, 2021

Atrys continues M&A splurge as shares soar

Spanish listed precision medicine, diagnostics and radiotherapy group Atrys Health continued its relentless M&A drive through 2020 and has started 2021 with its biggest deal yet. But how much is too much?
February 11, 2021

Integrating diagnostics and therapeutics

Diagnosing and giving therapy can be two very siloed services. Increasingly, innovators are building platforms to understand how the two could come closer together. We speak to one of the world's best-funded AI start-ups, Lunit, about its attempt to integrate diagnostics and therapeutics.
February 4, 2021

Metropolis buys big in India, targets further growth

India-based lab group Metropolis Healthcare has bought big in South India, acquiring a network of 31 laboratories and 68 collection centres to its network. The combined entity confirms its position as the second-largest diagnostics company in India and the largest brand in South and West India. Further acquisitions by large Indian diagnostics players are expected.
January 21, 2021

Biogroup ‘buying’ €100m French lab

France's largest lab group Biogroup is reportedly continuing its consolidation of the French market and in exclusive negotiations to acquire much smaller competitor Oriade Noviale.
January 21, 2021

Denmark tenders €200m lab services for COVID-19

The Danish regions want to spend just over €201m on collection and analysis services for COVID-19 PCR and antigen tests. This is more than 13x what the market's largest players - Unilabs and Synlab - earnt in the market in 2019.
January 7, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us